Sokolov, V., Yakovleva, T., Chu, L., Tang, W., Greasley, P. J., Johansson, S., . . . Penland, R. C. (2020). Differentiating the Sodium‐Glucose Cotransporter 1 Inhibition Capacity of Canagliflozin vs. Dapagliflozin and Empagliflozin Using Quantitative Systems Pharmacology Modeling. CPT Pharmacometrics Syst Pharmacol.
Style de citation ChicagoSokolov, Victor, et al. "Differentiating the Sodium‐Glucose Cotransporter 1 Inhibition Capacity of Canagliflozin Vs. Dapagliflozin and Empagliflozin Using Quantitative Systems Pharmacology Modeling." CPT Pharmacometrics Syst Pharmacol 2020.
Style de citation MLASokolov, Victor, et al. "Differentiating the Sodium‐Glucose Cotransporter 1 Inhibition Capacity of Canagliflozin Vs. Dapagliflozin and Empagliflozin Using Quantitative Systems Pharmacology Modeling." CPT Pharmacometrics Syst Pharmacol 2020.